CLINICAL_TRIALS
trial_result
· 2021-07-26
Clinical Trial Update: A Study Investigating the Efficacy and Safety of Sepranolone in Women With Menstrual Migraine [Phase 2]
Summary
Phase 2 trial evaluating efficacy and safety of Sepranolone in women with menstrual migraine has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Asarina Pharma | Conditions: Menstrual Migraine | Phase 2 | Status: COMPLETED